verified
SJR 1,18 · Q1
•
database
Scopus / SJR & Web of Science indexed
United Kingdom · SAGE Publications Inc.
workspace_premium
Q1 — Hematology
Therapeutic Advances in Hematology
Therapeutic Advances in Hematology is a journal indexed in SJR in Hematology with an H index of 39. It has an SJR impact factor of 1,18 and it has a best quartile of Q1. It has an SJR impact factor of 1,18.
ISSN: 2040-6207
Publisher: SAGE Publications Inc.
Category: Hematology
Indexation:
verifiedScopus / SJR
verifiedWeb of Science
open_in_new Portal NPD
menu_book Guidelines NPD
schedule
CountryOfPapers database fields
SJR Impact Factor
trending_up
1,18
Q1
H-index
39
Acceptance rate
pie_chart
36%
Source
Acceptance_Rate
Time to publication
hourglass_top
NPD
Field
NPD
Publication cost (APC)
payments
NPD
Non-OA path
NPD
Metrics
Scimago and CountryOfPapers database fields
Scopus / SJR
Web of Science
SJR Impact
1,18
H-index
39
Docs (year)
64
Docs 3y
163
Total refs
2853
Cites 3y
542
Citable 3y
160
Cites/Doc 2y
3.22
Ref/Doc
44.58
Immediate OA
—
Embargoed OA
NPD
Non OA / Submission
—
shield
Researcher voice
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Fair & fast peer review
Clear APC / no surprise fees
Suspected predatory
Fake impact claims
Researcher reviews
sentiment_dissatisfied
No reviews yet — be the first to share an honest experience.